The Journal of Urology
Volume 176, Issue 4 , Pages 1631-1635, October 2006

Increased Serum Leptin Levels and Over Expression of Leptin Receptors are Associated With the Invasion and Progression of Renal Cell Carcinoma

  • Akio Horiguchi

      Affiliations

    • Department of Urology, National Defense Medical College, Tokorozawa-City, Saitama, Japan
    • Urological Oncology Research Laboratory, Department of Urology, Weill Medical College of Cornell University, New York, New York
    • Corresponding Author InformationCorrespondence and requests for reprints: Urological Oncology Research Laboratory, Department of Urology, Weill Medical College of Cornell University, 525 East 68th St., E-300, New York, New York 10021 (telephone: 1-212-746-5495; FAX: 1-212-746-8941)
  • ,
  • Makoto Sumitomo

      Affiliations

    • Department of Urology, National Defense Medical College, Tokorozawa-City, Saitama, Japan
  • ,
  • Junichi Asakuma

      Affiliations

    • Department of Urology, National Defense Medical College, Tokorozawa-City, Saitama, Japan
  • ,
  • Takako Asano

      Affiliations

    • Department of Urology, National Defense Medical College, Tokorozawa-City, Saitama, Japan
  • ,
  • Rong Zheng

      Affiliations

    • Urological Oncology Research Laboratory, Department of Urology, Weill Medical College of Cornell University, New York, New York
  • ,
  • Tomohiko Asano

      Affiliations

    • Department of Urology, National Defense Medical College, Tokorozawa-City, Saitama, Japan
  • ,
  • David M. Nanus

      Affiliations

    • Urological Oncology Research Laboratory, Department of Urology, Weill Medical College of Cornell University, New York, New York
    • Financial interest and/or other relationship with Amgen.
  • ,
  • Masamichi Hayakawa

      Affiliations

    • Department of Urology, National Defense Medical College, Tokorozawa-City, Saitama, Japan

Received 10 October 2005

Purpose

Leptin, an adipocyte derived cytokine that is closely associated with obesity, was recently shown to be involved in carcinogenesis and cancer progression. Because obesity is a significant risk factor for renal cell carcinoma, we investigated the link between leptin and the development of renal cell carcinoma.

Materials and Methods

Associations between preoperative serum leptin levels and leptin receptor expression in tumor specimens and various clinicopathological parameters were analyzed in 57 patients with renal cell carcinoma.

Results

Serum leptin levels were 1.2 to 16.2 ng/ml (mean 4.5). Of 57 tumors 22 (38.6%) demonstrated high leptin receptor expression. Serum leptin levels were significantly higher in patients with vs without tumor specimen venous invasion (p = 0.030) and higher in patients with high vs low leptin receptor expression (p = 0.019). There were significant associations between high leptin receptor expression and the presence of venous invasion (p = 0.013), histological type (p = 0.0076) and regional lymph node metastasis (p = 0.047). Of 42 patients with N0M0 disease those with serum leptin 5.0 ng/ml or more had significantly shorter progression-free survival than patients with lower levels (p = 0.0043). Multivariate Cox proportional hazards model analysis demonstrated that higher serum leptin was an independent predictor of progression-free survival (p = 0.0406).

Conclusions

Leptin and leptin receptor could have a key role in the invasion of renal cell carcinoma and they could be valuable predictors of progression.

Key Words:  kidney , carcinoma , renal cell , obesity , leptin , neoplasm invasiveness

Abbreviations and Acronyms:  BMI, body mass index , Ob-R, leptin receptor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5347(06)01415-7

doi:10.1016/j.juro.2006.06.039

The Journal of Urology
Volume 176, Issue 4 , Pages 1631-1635, October 2006